FC29 peptide (University of Queensland)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFC29 peptide (University of Queensland)
Drug Alias NameNeuroprotect (University of Queensland)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTumor necrosis factor receptor superfamily member 1B modulatorsTropomyosin-related kinase modulators
TargetsTumor necrosis factor receptor superfamily member 1BTropomyosin-related kinase
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniquest Pty LtdThe University Of Queensland
Active IndicationsN/A
Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A
Related LinksN/A